MARK TRIPLETT: Open Payments
NPI 1508192519 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 11 payments from 6 companies in 2025. Trend: 2023 $515 · 2024 $289 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $213 |
| Abbott Laboratories | 3 | $185 |
| Boston Scientific Corporation | 1 | $147 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Nalu Medical, Inc. | 1 | $16 |
Products named: General - Therapies, PRODIGY, JOURNAVX, ETERNA, AZMIRO, RELISTOR, Nalu Neurostimulation System, PROCLAIM.
Industry payments across AZ — which companies pay providers there.
